Xencor reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 37.16B 1.46B
AstraZeneca AZN:LN USD 23.68B 3.47B
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 36.97B 141M
Cytokinetics CYTK:US USD 609.73M 411.31M
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Novartis NOVN:VX USD 21.24B 2.55B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K